Literature DB >> 2308634

Self-tolerance to transgenic gamma delta T cells by intrathymic inactivation.

M Bonneville1, I Ishida, S Itohara, S Verbeek, A Berns, O Kanagawa, W Haas, S Tonegawa.   

Abstract

During their intrathymic differentiation, T lymphocytes expressing alpha beta T-cell receptors (TCR) are negatively and positively selected. This selection contributes to the establishment of self-tolerance and ensures that mature CD4+ and CD8+ cell populations are restricted by the self major histocompatibility complex. Little is known, however, about gamma delta T-cell development. To investigate whether selection operates in the establishment of the gamma delta T-cell class, we have generated transgenic mice using gamma- and delta-transgenes encoding a TCR that is specific for a product of a gene in the TL-region of the TLb haplotype. Similar numbers of thymocytes expressing the transgenic TCR were generated in mice of TLb and TLd haplotypes. But gamma delta thymocytes from TLb and TLd transgenic mice differed in cell size, TCR density and in their capacity to respond to TLb stimulator cells or interleukin-2 (IL-2). In contrast to gamma delta T cells from TLd transgenic mice, gamma delta T cells from TLb transgenic mice did not produce IL-2 and did not proliferate in response to TLb stimulator cells, but they did proliferate in the presence of exogenous IL-2. These results indicate that functional inactivation of self-antigen-specific T cells could contribute to the establishment of self-tolerance to thymic determinants.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2308634     DOI: 10.1038/344163a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  28 in total

Review 1.  Tissue distribution, antigen specificity and effector functions of gamma delta T cells in human diseases.

Authors:  G De Libero
Journal:  Springer Semin Immunopathol       Date:  2000

2.  CD3 delta deficiency arrests development of the alpha beta but not the gamma delta T cell lineage.

Authors:  V P Dave; Z Cao; C Browne; B Alarcon; G Fernandez-Miguel; J Lafaille; A de la Hera; S Tonegawa; D J Kappes
Journal:  EMBO J       Date:  1997-03-17       Impact factor: 11.598

Review 3.  Maturation, selection and specificity of Tcr gamma delta T cells.

Authors:  L Lefrançois
Journal:  Immunol Res       Date:  1992       Impact factor: 2.829

4.  Effects of cyclosporin A on T-cell development in organ-cultured foetal thymus.

Authors:  Y Takeuchi; T Horiuchi; T Sugimoto; H Matsuda; H Yagita; K Okumura
Journal:  Immunology       Date:  1990-10       Impact factor: 7.397

Review 5.  Specificity and selection of gamma-delta receptor-expressing T cells.

Authors:  L Matis
Journal:  Immunol Res       Date:  1991       Impact factor: 2.829

Review 6.  Heat-shock proteins and the gamma delta T cell response in virus infections: implications for autoimmunity.

Authors:  P C Doherty; W Allan; M Eichelberger; S R Carding
Journal:  Springer Semin Immunopathol       Date:  1991

Review 7.  Control of self-reactivity in the intestine.

Authors:  T A Barrett; S M Hedrick; A L Dent; M L Delvy; D M Kennedy; L A Matis; J A Bluestone
Journal:  Immunol Res       Date:  1991       Impact factor: 2.829

8.  Unresponsiveness to Mlsa induced in newborn Mlsb mice by maternal preimmunization.

Authors:  A Matossian-Rogers; L DeGiorgi; L DeGiori
Journal:  Immunology       Date:  1991-02       Impact factor: 7.397

9.  The T cell receptor repertoire of intestinal intraepithelial gammadelta T lymphocytes is influenced by genes linked to the major histocompatibility complex and to the T cell receptor loci.

Authors:  P Pereira; J J Lafaille; D Gerber; S Tonegawa
Journal:  Proc Natl Acad Sci U S A       Date:  1997-05-27       Impact factor: 11.205

10.  Human V delta 2+ gamma delta T-cell tolerance to foreign antigens of Toxoplasma gondii.

Authors:  T Hara; S Ohashi; Y Yamashita; T Abe; H Hisaeda; K Himeno; R A Good; K Takeshita
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-14       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.